Health Condition 1: I429- Cardiomyopathy, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Confirmed HFpEF patients n is equal to 150 Diagnosed according to ESC guidelines with LVEF greaterthan or equal to 50 percent Asymptomatic individuals with risk factors n is equal to 500 Age and gender matched participants but no symptoms and normal NT proBNP n is equal to 125 Patients with established systemic auto-immune conditions and evidence of a pro-inflammatory state patients with rheumatoid arthritis systemic lupus erythematosus mixed connective tissue disorder scleroderma systemic sclerosis or systemic vasculitis with high-sensitivity C-reactive protein hs CRP greater than 3 mg or dL n is equal to 150 Healthy controls n is equal to 750 No cardiovascular risk factors or abnormalities
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the outcomes of patients with HFpEFTimepoint: At 1 year 2 Years | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare the patients echocardiograms with normal controls and analyse the echocardiograms using AI.Timepoint: Yearly upto 2 Years | — |
Countries
India
Contacts
Public ContactDr Srilakshmi M A
St. Johns Medical college Hospital
Outcome results
None listed